Purpose: To assess the relationship between day 1 postoperative intraocular pressure (IOP) and patient demographic information, indication for vitrectomy, lens status, tamponade medium (air, perfluoroethane, sulfur hexafluoride), and laser treatment.
Introduction
The issue of intraocular pressure (IOP) on day 1 post pars plana vitrectomy (PPV) is up for considerable debate. 1, 2 Over 25 years ago, Han et al 3 reported a significant rise in IOP immediately following the procedure. It has been a common practice to assess the majority of such patients on day 1 postoperatively. This brings with it a considerable economic and personal burden to both patients and clinicians.
Since then, there has been much advancement in vitrectomy techniques, in particular the usage of transconjunctival sutureless, small-gauge ports, which have had a greatly positive impact on postoperative IOP. Ahn et al 4 have provided compelling evidence for this, with a 0.5% incidence of elevated IOP post 23-G vitrectomy compared to 22.9% reported by other authors 5 in patients undergoing 20-G vitrectomy. A recent study by Alexander et al reported that the incidence of day 1 postvitrectomy raised IOP is low with the use of postoperative prophylactic antiglaucoma treatment. 6 Therefore, a current trend is to use immediate prophylactic oral or topical antiglaucoma medication to justify avoidance of day 1 postoperative review. However, the evidence to support this approach is currently deficient and it remains questionable whether prophylactic treatment is essential in all vitreoretinal cases. In addition, it has been suggested that gas tamponade, as opposed to air, has more of an IOP elevation effect; however, there is limited evidence to support this. 6 With the growing evidence that raised IOP is unlikely to be a significant problem following PPV, in this study, we aim to identify risk factors such as type of tamponade used, lens status, and the number of laser burns applied to inform clinicians as to which patients may not require day 1 follow-up.
Methods
A prospective consecutive case series was conducted. Patient information was collected prospectively and reviewed retrospectively. All patients were recruited and operated by a single surgeon at the Calderdale Royal Hospital between January 2013 and July 2016.
All patients underwent primary (23/25/27 gauge) transconjunctival pars plana vitrectomy (TSV [transconjunctival sutureless vitrectomy]) with 1-step sutureless valved channels (Constellation; Alcon, Fort Worth, Texas). A noncontact wide-angle viewing system (Resight 500; Carl Zeiss Meditec, Jena, Germany) was used for viewing posterior segment. Inclusion criteria were patients undergoing PPV for macular hole (MH), epiretinal membrane (ERM), or rhegmatogenous retinal detachment (RRD). TSV was combined with microincisional phacoemulsification through a 2.2 mm incision in all phakic patients. Endolaser or cryotherapy was used for retinopexy. Air, sulfur hexafluoride (SF 6 20%), or perflouropropane (C 2 F 6 20%) was used as endotamponade agents. None of the sutureless ports required suturing at the end of the vitrectomy.
Patients were stratified according to demographic information, vitrectomy gauge, lens status, indication for surgery (ERM, MH, and RRD), tamponade medium (air, C 2 F 6 , or SF 6 ), laser treatment, and number of burns.
We excluded patients with coexisting conditions such as ocular hypertension, glaucoma, and diabetic or nondiabetic vitreous hemorrhage. The silicone oil group was excluded due to fewer numbers compared to other tamponade groups to balance all groups for statistical purposes. None of the patients had scleral buckling combined with vitrectomy.
All patients were seen on their first postoperative day. Slitlamp biomicroscopy was performed and IOP measurements were taken by Goldmann applanation. None of the patients in the study received any immediate postoperative prophylactic antiglaucoma medications.
Primary end points were raised IOP of over 30 mm Hg or hypotony (IOP of less than 8 mm Hg). There were no secondary outcome measures.
The sample was summarized descriptively. Multiple linear regression analysis was conducted to assess the relationship between postoperative IOP and the predictors outlined above: patient demographic information (age and gender), lens status, vitrectomy gauge, tamponade medium (air, C 2 F 6 , or SF 6 ), laser treatment, type of procedure (vitrectomy for ERM, MH, or RRD), and the number of laser burns applied. The extent of missing data was assessed, but no loss to follow-up analysis was performed. A sequential modeling strategy (with backward elimination applied within blocks) was utilized to derive a parsimonious regression model, with higher priority variables entered in later blocks. Liberal criteria (P < .1) were used to remove variables from the model. Demographic parameters were entered as an initial block, treatment parameters in a second block, and type of surgery (dichotomized into macular surgery [ERM and MH] and vitrectomy for RRD) alone in the final block. Parameter estimates were derived to assess the effect of significant predictors on the outcome, controlling for other variables. P values and confidence intervals (CIs) were also reported. The goodness of fit of the final model was assessed using the adjusted R 2 statistic, and regression assumptions were checked using residual analysis.
Results
Of an initial cohort of 183 patients, 22 were excluded as they had a history of ocular hypertension/glaucoma and/or were treated with silicone oil, leaving 161 eligible patients. Patient demographics, lens status, tamponade medium, laser treatment, type of surgery, and number of burns for these patients are summarized in Table 1 . The vitrectomy gauge used for ERM, RRD, or MH was recorded. All patients underwent TSV, 35% 27 G, 18% 25 G, 47% had 23 G. None of the patients had 20-G surgery.
The most used gauge was 23 G across all diagnoses (n ¼ 75), and the majority of cases were phakic (n ¼ 142). None of our patients had intraoperative anterior segment complications such as iris trauma, zonular dehiscence, or posterior capsule rupture, and all lenses (MI60) were implanted in the capsular bag. None of the patients had severe anterior segment inflammation/fibrinous uveitis, hyphema, or shallowing of the anterior chamber on day 1 review.
Incidence of IOP (defined as !30 mm Hg) was noted in 10 (6%) patients. Hypotony (IOP < 8 mm Hg) was noted in 5 (3%) patients, all of which resolved spontaneously. All patients received air or gas tamponade; none of the eyes were fluid filled at the end of the surgery. Thirty-seven patients had air tamponade, while 124 had gas tamponade (SF 6 in 53 eyes and C 2 F 6 in 71 eyes). The sample is summarized in Table 1 .
Regression Model
Neither of the demographic parameters (gender, age) were carried forward from the first block to a block including 
Gas Tamponade
Controlling for other variables, patients treated with C 2 F 6 had IOP values 3.03 units higher than those treated with air (95% CI: 0.325-5.73, P ¼ .028). Patients treated with SF 6 had IOP values 2.50 units higher than those treated with air (95% CI: À0.180 to 5.187, P ¼ .067).
Number of Burns
Controlling for other variables, each additional burn was associated with a raised IOP of 0.003 units (95% CI: 0.000-0.006, P ¼ .028). No other substantive associations were found. The adjusted R 2 statistic for the final model was 0.071, indicating a moderately well-fitting model. Examination of residuals revealed no evidence for violation of regression assumptions; residuals were normally distributed and no discernible patterns were apparent in a plot of standardized residuals against standardized predicted values.
Discussion
Examples of elevated IOP post 20-G vitrectomy is well documented in the literature. [3] [4] [5] However, recent advancements in the usage of TSV PPV has significantly reduced the risk of elevated IOP postoperatively. A recent paper published by Ahn et al 4 presented compelling evidence that 20-G vitrectomy had considerably worse IOP readings as compared to 23 G. Previous studies have argued for the use of prophylactic antiglaucoma treatment prior to surgery, on the basis of observed elevated postoperative IOP. 6 A study by Muether et al 5 observed a 29.5% IOP elevation in the first 24 hours after vitreoretinal surgery. However, the majority of these cases used a 20-G vitrectomy. In our study, the use of 23-G or smaller gauge vitrectomy may have lowered the incidence of elevated IOP observed on the first day postsurgery. In addition, transient isolated spikes of IOP are likely to occur postoperatively, so a raised IOP on day 1 may not be indicative of sustained problematic IOP as a result of PPV.
Of course raised IOP is not the only complication of PPV, with endophthalmitis and wound leaks perhaps being the most dangerous. Endophthalmitis is highly unlikely to occur on the first day after surgery, rather having a clinical course starting a few days after surgery. It is unlikely that a routine check day 1 postoperatively will spot this. None of the patients in our cohort had endophthalmitis or wound leak. Wound leak is becoming less and less of an issue with the advent of sutureless ports and regular use of air tamponade in all cases. It often tends to be transient and resolve spontaneously.
None of our patients had any anterior segment complications such as fibrinous uveitis/hyphema/shallow anterior chamber on day 1 review. There was no cases of posterior capsular rupture.
This study shows that the incidence of elevated IOP on day 1 post PPV without prophylactic IOP-lowering medication is low. With much documented elsewhere about the low risk of elevated IOP post PPV, and therefore the lack of need for day 1 reviews, little however has been shown to identify which surgical retina patients do require such a review. Comparisons we performed have not received research attention until now, particularly assessing gas versus air tamponade and the number of laser burns. Prior studies 5 have tended to combine factors that predispose to elevated IOP such as scleral buckling, silicone oil, and preoperative vitreous hemorrhage. We have performed a more focused analysis of risk factors in specific group of patients to provide a clearer assessment of true IOP measurement postsurgery.
Muether et al 5 observed a 29.5% IOP elevation in the first 24 hours after vitreoretinal surgery. However, this study included patients undergoing 20-G vitrectomy combined with scleral buckling, silicone oil in complex diabetic/RRD, and trauma cases. Our study focused on a selected group of patients and reported an incidence of 6% day 1 postoperative IOP, without prophylactic treatment. Brennan et al 1 recently reported a 0.5% incidence of raised IOP on day 1 postvitrectomy and have justified omitting first day review of low-risk TSV procedures.
One study performed by Framme et al 7 in 851 patients comparing air versus SF 6 versus silicone oil showed that gas tamponade was associated with a prolonged elevated IOP; however, the most significant risk factor for elevated IOP was the use of silicone oil.
Our results show that transient minimal elevations in IOP are associated with the number of laser burns and gas. However, this does not warrant prophylactic antiglaucoma medication in all cases and is only justified in high-risk patients. We did not establish a relationship between the variables of vitrectomy gauge, lens status, or indications for surgery (ERM, MH, or RRD). However, previously Yang et al 8 have shown in a comparative study that phacovitrectomy was associated with a higher risk of IOP elevation during the early postoperative period than PPV alone. We argue that there is no added reason for antiglaucoma treatment in gas use over air, in terms of reduced risk of IOP elevation.
Conclusion
The use of gas tamponade, in particular C 2 F 6 , does not constitute justification for preoperative antiglaucoma, prophylactic treatment. In addition, careful consideration should be given to the frequency of laser burns during PPV. We argue that assessing singular rather than combined factors in a robust model will enable surgeons to effectively differentiate those cases which may or may not require prophylactic antiglaucoma treatment; however in the majority of cases, such prophylaxis is not required. Further studies will hopefully establish a revised evidence-based argument and guidelines for the routine use of antiglaucoma treatment prior or post vitrectomy to be reduced or removed.
What we already know:
There is still a common trend to have day 1 postoperative review. There is growing evidence that elevated IOP is rare in patients who have had PPV. Smaller gauges and sutureless ports are associated with lower and more stable postoperative IOP compared to 20-G vitrectomy.
What this study adds:
There is little to support a conclusion that the use of gas tamponade leads to raised IOP post PPV. There is a moderate association between the number of laser burns and raised IOP.
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